NCT04993261Active, not recruitingEarly phase 1
An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors
Evaluation of Dual Energy CT for the Detection of Gastrointestinal Carcinoids
Source: ClinicalTrials.gov · Last updated 11 Aug 2026
Brief summary (registry, in English)
This trial studies the use of a special type of computed (CT) scan called dual energy CT in detecting gastrointestinal carcinoid tumors. CT is an imaging technique that uses x-rays and a computer to create images of areas inside the body. Dual energy computed tomography is a technique used during routine CT scans to help obtain and process the image after the scan is complete. Doctors want to learn if dual energy computed tomography can help improve the detection of carcinoid tumors during routine CT scans.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 71 (actual)
- First submitted
- 21 Jul 2021
- Start date
- 23 Sept 2015
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Neuroendocrine tumours
- NCT number
- NCT04993261
What you commit to
- Study type: Interventional · Early phase 1
- Participants enrolled: 71
- From 23 Sept 2015 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Contraindication to intravenous contrast agents (e.g. allergy, renal failure, dialysis, pregnancy etc.).
Other
- Patients who have already had their primary GI carcinoid resected.
- Pregnant patients.
Who the study is looking for
- Patients with: clinical features of carcinoid syndrome (or) increased serum and urinary markers suggestive of carcinoid (or) endoscopic biopsy proven carcinoid (or) metastases which are biopsy proven as carcinoid.
- Patient is scheduled to have a clinically indicated staging CT exam.
- Patients who have signed their informed consent form to undergo the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| M D Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.